Medistim Asa Stock Price To Sales
| MEDI Stock | NOK 177.00 1.00 0.56% |
Medistim ASA fundamentals help investors to digest information that contributes to Medistim ASA's financial success or failures. It also enables traders to predict the movement of Medistim Stock. The fundamental analysis module provides a way to measure Medistim ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medistim ASA stock.
Medistim |
Medistim ASA Company Price To Sales Analysis
Medistim ASA's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Medistim ASA Price To Sales | 9.15 X |
Most of Medistim ASA's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medistim ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Medistim ASA has a Price To Sales of 9.1466 times. This is 57.26% lower than that of the Healthcare sector and 91.35% higher than that of the Medical Devices industry. The price to sales for all Norway stocks is 19.91% higher than that of the company.
Medistim Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medistim ASA's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medistim ASA could also be used in its relative valuation, which is a method of valuing Medistim ASA by comparing valuation metrics of similar companies.Medistim ASA is currently under evaluation in price to sales category among its peers.
Medistim Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 4.12 B | |||
| Shares Outstanding | 18.26 M | |||
| Shares Owned By Insiders | 14.97 % | |||
| Shares Owned By Institutions | 73.95 % | |||
| Price To Earning | 36.32 X | |||
| Price To Book | 12.24 X | |||
| Price To Sales | 9.15 X | |||
| Revenue | 417.82 M | |||
| Gross Profit | 320.7 M | |||
| EBITDA | 137.68 M | |||
| Net Income | 90.9 M | |||
| Cash And Equivalents | 129.49 M | |||
| Cash Per Share | 2.99 X | |||
| Total Debt | 17.08 M | |||
| Debt To Equity | 3.40 % | |||
| Current Ratio | 3.68 X | |||
| Book Value Per Share | 18.94 X | |||
| Cash Flow From Operations | 128.14 M | |||
| Earnings Per Share | 5.34 X | |||
| Target Price | 290.0 | |||
| Number Of Employees | 116 | |||
| Beta | 0.75 | |||
| Market Capitalization | 4.24 B | |||
| Total Asset | 403.24 M | |||
| Working Capital | 93 M | |||
| Current Asset | 136 M | |||
| Current Liabilities | 43 M | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 2.62 % | |||
| Net Asset | 403.24 M | |||
| Last Dividend Paid | 3.75 |
About Medistim ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medistim ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medistim ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medistim ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Medistim ASA using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Other Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.